Estrella Immunopharma, Inc.
ESLA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001844417
No open-market purchases or sales by Estrella Immunopharma, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $4.99M in total; no superinvestor holds it.
Other share classesESLAW
Holders of 5% or more of ESLA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Estrella Immunopharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Estrella Immunopharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Estrella Immunopharma, Inc., newest first.
No Schedule 13D or 13G filings on Estrella Immunopharma, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Estrella Immunopharma, Inc. shares.
No Form 144 notices for Estrella Immunopharma, Inc. are on file.